Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
FDA’s New Nicotine-Focused Regulatory Framework Supported by Evidence Reviews on Electronic...
lungcanc
Q&A with Dr. D. Ross Camidge
lungcanc
Keeping It Personal: CMS-Proposed Coverage Restrictions for NGS Challenge Innovation in...
lungcanc
Breaking News Briefs
lungcanc
ESMO-IASLC European Lung Cancer Congress
lungcanc
European Perspective on ALCHEMIST
lungcanc
Lung Cancer 360 Forum Overview: C.A.I.R.O Journal Club’s Fourth Anniversary
lungcanc
Using Deep Learning Systems to Radiologically Predict Pathologic Invasiveness in Lung...
lungcanc
Q&A with TMB Expert Dr. Solange Peters
lungcanc
Management of Pulmonary Nodules Detected by CT Screening
lungcanc
1
...
26
27
28
...
53
Page 27 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
